This useful interaction concerning the serotoninergic and central dopaminergic programs has actually been shown in experiments with haloperidol, a D2 receptor antagonist that attenuates the psychotomimetic outcomes of psilocybin [5].Psilocybin that contains mushrooms: a promptly acquiring biotechnology market in the psychiatry, biomedical and nutra